GE says bye-bye to biotech. … So it goes.

By |2020-01-01T08:45:00-05:00February 25th, 2019|Biotechnology, Patent|

February 25, 2019  — The Wall Street Journal headline reads: GE to Sell Its Biotech Business for $21 Billion.  I now know for certain that we're in a topsy-turvy world. Back in 1980 it was lawyers for the General Electric company that persuaded the U.S. Supreme Court to affirm, in the legendary decision of Diamond v. [...]